Our customers' Feedback
Search:
Perform search
Categories list

Get Reminyl

News
Reminyl
Reminyl photo

Get Reminyl (Galantamine)

Alzheimer's And Parkinson's

PackagePricePer pillSavingsOrder
4mg × 10 pills£15.93£1.59Add to cart
4mg × 20 pills£25.51£1.28£6.35Add to cart
4mg × 30 pills£35.09£1.17£12.71Add to cart
4mg × 60 pills£63.83£1.06£31.77Add to cart
4mg × 90 pills£92.57£1.03£50.83Add to cart
4mg × 120 pills£121.30£1.01£69.89Add to cart

PackagePricePer pillSavingsOrder
8mg × 10 pills£28.71£2.87Add to cart
8mg × 20 pills£44.67£2.23£12.74Add to cart
8mg × 30 pills£57.44£1.91£28.67Add to cart
8mg × 60 pills£111.72£1.86£60.51Add to cart
8mg × 90 pills£166.00£1.84£92.34Add to cart
8mg × 120 pills£204.32£1.70£140.14Add to cart

Most popular quantity.

Products from the same category

Social bookmarks:
    Choose your language:



    Money backguarantee
    Secureshopping

    Our billing is certified by:

    Secure shopping certificates

    Special Offer!

    • This RSS feed URL is deprecated

      This RSS feed URL is deprecated, please update.

    • Cognition and Memory Enhancement Drugs: Technologies and Global Markets - Markets Insider

      Cognition and Memory Enhancement Drugs: Technologies and Global MarketsMarkets InsiderThe cognition and memory-enhancing drugs market is segmented mainly into eight components: Aricept, Exelon, Reminyl, Namenda, Adderall, Ritalin, Dexedrin, and other cognition drugs.

    • Alzheimer drugs halted - The Connexion

      Alzheimer drugs haltedThe ConnexionFour Alzheimer drugs costing the health service €90million a year will no longer be reimbursed as the ministry moves to stop them being prescribed due to harmful side effects, which include falls and broken bones.

    • Global Cognition & Memory Enhancement Drugs Market 2018-2022: Drivers, Trends and Opportunities - GlobeNewswire (press release)

      Global Cognition & Memory Enhancement Drugs Market 2018-2022: Drivers, Trends and OpportunitiesGlobeNewswire (press release)The cognition and memory-enhancing drugs market is segmented mainly into eight components: Aricept, Exelon, Reminyl, Namenda, Adderall, Ritalin, Dexedrin, and other cognition drugs.

    • 'Government support for dementia tests might be ill-timed' - Korea Biomedical Review

      Korea Biomedical Review'Government support for dementia tests might be ill-timed'Korea Biomedical ReviewMarketed ACEIs include Eisai Korea's Aricept (ingredient: donepezil), Novartis Korea's Exelon (rivastigmine), and Janssen Korea's Reminyl (galatamine).

        Copyright © www.ohnerezeptfreikauf.com is an affiliate marketing website. All rights reserved.